help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on July 10, 2007
Molecular Endocrinology, doi:10.1210/me.2007-0176
A more recent version of this article appeared on October 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
21/10/2350    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Quignodon, L.
Right arrow Articles by Flamant, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Quignodon, L.
Right arrow Articles by Flamant, F.

Submitted on April 6, 2007
Accepted on July 5, 2007

A point mutation in the AF-2 domain of thyroid hormone receptor alpha1 expressed after CRE mediated recombination partially recapitulates hypothyroidism

Laure Quignodon, Séverine Vincent, Harald Winter, Jacques Samarut, and Frédéric Flamant*

Institut de Génomique Fonctionnelle de Lyon; Université de Lyon; Institut Fédératif Biosciences Gerland Lyon Sud; Université Lyon 1, CNRS, INRA, Ecole Normale Supérieure de Lyon, France; *University of Tübingen, Tübingen Hearing Research Centre, Laboratory of Molecular Neurobiology

* To whom correspondence should be addressed. E-mail: Frederic.Flamant{at}ens-lyon.fr.

Thyroid hormones act directly on transcription by binding to TR{alpha}1, TR{beta}1, TR{beta}2 nuclear receptors, regulating many aspects of post-natal development and homeostasis. To precisely analyze the implication of the widely expressed TR{alpha}1 isoform in this pleiotropic action, we have generated transgenic mice with a point mutation in the TR{alpha}1 coding sequence, which is expressed only after CRE/loxP mediated DNA recombination. The amino-acid change prevents interaction between TR{alpha}1 and histone acetyltransferase coactivators and the release of corepressors. Early expression of this dominant-negative receptor deeply affects post-natal development and adult homeostasis, recapitulating many aspects of congenital and adult hypothyroidism, except in tissues and cells where TR{beta}1 and TR{beta}2 are predominantly expressed. Both respective abundance and intrinsic properties of TR{alpha}1 and TR{beta}1/2 seems to govern specificity of action.


Key words: Thyroid hormone receptor • transgenic mice • development

NURSA Molecule Pages Link:

Nuclear Receptors:   TRα  |  TRβ
Coregulators:   SRC-1  |  GRIP1  |  NCOR
Ligands:   Thyroid hormone






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society